Evidence map›Paper›PMID 34364578›Full record

ArticleCarbohydrate polymers2021

Vanillin-bioglass cross-linked 3D porous chitosan scaffolds with strong osteopromotive and antibacterial abilities for bone tissue engineering.

Jue Hu, Zhuozhi Wang, Jacob M Miszuk, Min Zhu, Thiranjeewa I Lansakara, Alexei V Tivanski, Jeffrey A Banas, Hongli Sun

Abstract read
In one paragraph

Article in Carbohydrate polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Chitosan Cross-Linking with Acetaldehyde Acetals.Biomimetics (Basel, Switzerland) · 2022
    Article
  12. Review
  13. Article
  14. A Composite of Cubic Calcium-Magnesium Sulfate and Bioglass for Bone Repair.Frontiers in bioengineering and biotechnology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jue HuDepartment of Oral and Maxillofacial Surgery, University of Iowa College of Dentistry, Iowa City, IA 52242, USA; Iowa Institute for Oral Health Research, University of Iowa College of Dentistry, Iowa City, IA 52242, USA.
Zhuozhi WangDepartment of Oral and Maxillofacial Surgery, University of Iowa College of Dentistry, Iowa City, IA 52242, USA; Iowa Institute for Oral Health Research, University of Iowa College of Dentistry, Iowa City, IA 52242, USA.
Jacob M MiszukDepartment of Oral and Maxillofacial Surgery, University of Iowa College of Dentistry, Iowa City, IA 52242, USA; Iowa Institute for Oral Health Research, University of Iowa College of Dentistry, Iowa City, IA 52242, USA.
Min ZhuIowa Institute for Oral Health Research, University of Iowa College of Dentistry, Iowa City, IA 52242, USA.
Thiranjeewa I LansakaraDepartment of Chemistry, University of Iowa, Iowa City, IA 52242, USA.
Alexei V TivanskiDepartment of Chemistry, University of Iowa, Iowa City, IA 52242, USA.
Jeffrey A BanasIowa Institute for Oral Health Research, University of Iowa College of Dentistry, Iowa City, IA 52242, USA.
Hongli SunDepartment of Oral and Maxillofacial Surgery, University of Iowa College of Dentistry, Iowa City, IA 52242, USA; Iowa Institute for Oral Health Research, University of Iowa College of Dentistry, Iowa City, IA 52242, USA. Electronic address: hongli-sun@uiowa.edu.

Funding

University of Iowa Institutional Training Program in Oral Health ResearchT90DE023520 · NIDCR · UNIVERSITY OF IOWA · PI STEVEN M. LEVY · 2013 to 2026
$5.6M
Rejuvenating aged bone regeneration by innovative nanomaterials-mediated drug deliveryR01DE029159 · NIDCR · UNIVERSITY OF IOWA · PI SUN, HONGLI · 2020 to 2024
$1.8M
NIDCR NIH HHS R01 DE029159NIDCR NIH HHS T90 DE023520
6 · The paper itself

Abstract

Chitosan scaffolds crosslinked by current methods insufficiently meet the demands of bone tissue engineering applications. We developed a novel effective crosslinking technique by using the natural and safe vanillin together with bioglass microparticles to generate an antibacterial, osteoconductive, and mechanically robust 3D porous chitosan-vanillin-bioglass (CVB) scaffold. In addition to the significantly improved mechanical properties, the CVB scaffolds had high porosity (>90%) and interconnected macroporous structures. Our data suggested that the crosslinking mainly resulted from the Schiff base reactions between the aldehydes of vanillin and amines of chitosan, together with the hydrogen and ionic bonds formed within them. Importantly, the CVB scaffolds not only showed good biocompatibility, bioactivity, and strong antibacterial ability but also significantly promoted osteoblastic differentiation, mineralization in vitro, and ectopic bone formation in vivo. Thus, the CVB scaffolds hold great promise for bone tissue engineering applications based on their robust mechanical properties, osteoconductivity, and antibacterial abilities.

Indexed as

AnimalsAnti-Bacterial AgentsBenzaldehydesBone and BonesBone RegenerationCell DifferentiationCell LineCeramicsChitosanFemaleMiceMice, Inbred C57BLOsteogenesisTissue EngineeringTissue ScaffoldsAnti-Bacterial AgentsBenzaldehydesBioglassChitosanvanillinAntibacterialBioglassBone tissue engineeringChitosanSchiff baseVanillin

Identifiers

PMID34364578
PMCPMC8353169

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.